PMID- 15101734 OWN - NLM STAT- MEDLINE DCOM- 20040728 LR - 20191108 IS - 1042-8194 (Print) IS - 1026-8022 (Linking) VI - 45 IP - 2 DP - 2004 Feb TI - Mantle cell lymphoma in lymph nodes with metastatic small cell carcinoma of lung: a diagnostic and treatment dilemma. PG - 409-14 AB - We report a rare case of small cell carcinoma (SCC) of lung, metastatic to ipsilateral hilar and peribronchial lymph nodes with synchronous mantle cell lymphoma (MCL), in a 58-year-old female. She was treated with Cisplatin, Etoposide, and Rituximab, and remained in complete remission for approximately two and a half years following the initial diagnosis. To the best of our knowledge, synchronous SCC and MCL or SCC metastatic to lymph nodes involved by MCL has not been previously reported. In this case, the features of MCL were very inconspicuous in the lymph nodes with extensive metastases of SCC. The presence of MCL was confirmed by immunohistochemistry and fluorescence in situ hybridization (FISH). The co-existence of lymphoma and metastatic carcinoma in the same lymph node, as seen in this case, highlights the significance of analyzing subtle lymphoid architectural changes, and applying ancillary studies such as immunohistochemistry and molecular analysis in suspicious cases. The management of synchronous SCC and MCL requires consideration of their respective biologic behavior, and cumulative toxicity of treatment regimens of both tumors. In such cases an optimum treatment strategy should be adopted to cover both malignancies with minimal toxic effect. FAU - Kampalath, Bal AU - Kampalath B AD - Department of Pathology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA. bkampal@yahoo.com FAU - Abed, Nashwa AU - Abed N FAU - Chitambar, Christopher R AU - Chitambar CR FAU - Vantuinen, Peter AU - Vantuinen P FAU - Chakrabarty, Gargi AU - Chakrabarty G FAU - Hanson, Gerald AU - Hanson G FAU - Rao, R Nagarjun AU - Rao RN FAU - Shidham, Vinod B AU - Shidham VB FAU - Chang, Chung-Che AU - Chang CC LA - eng PT - Case Reports PT - Journal Article PL - United States TA - Leuk Lymphoma JT - Leukemia & lymphoma JID - 9007422 RN - 0 (Antibodies, Monoclonal) RN - 0 (Antibodies, Monoclonal, Murine-Derived) RN - 0 (Antigens, CD20) RN - 0 (CD3 Complex) RN - 4F4X42SYQ6 (Rituximab) RN - 6PLQ3CP4P3 (Etoposide) RN - Q20Q21Q62J (Cisplatin) SB - IM MH - Antibodies, Monoclonal/therapeutic use MH - Antibodies, Monoclonal, Murine-Derived MH - Antigens, CD20/biosynthesis MH - CD3 Complex/biosynthesis MH - Carcinoma, Small Cell/*diagnosis/pathology/therapy MH - Cisplatin/therapeutic use MH - Etoposide/therapeutic use MH - Female MH - Humans MH - Immunohistochemistry MH - In Situ Hybridization, Fluorescence MH - Lung Neoplasms/*diagnosis/pathology/therapy MH - Lymph Nodes/*pathology MH - Lymphatic Metastasis MH - Lymphoma, Mantle-Cell/*diagnosis/pathology/therapy MH - Middle Aged MH - Remission Induction MH - Rituximab EDAT- 2004/04/23 05:00 MHDA- 2004/07/29 05:00 CRDT- 2004/04/23 05:00 PHST- 2004/04/23 05:00 [pubmed] PHST- 2004/07/29 05:00 [medline] PHST- 2004/04/23 05:00 [entrez] AID - 10.1080/1042819031000149395 [doi] PST - ppublish SO - Leuk Lymphoma. 2004 Feb;45(2):409-14. doi: 10.1080/1042819031000149395.